During Friday’s Current trade, Shares of Coca-Cola Enterprises Inc (NYSE:CCE), lost -1.05% to $48.27.
Coca-Cola Enterprises (CCE) has been named in the 2015 Dow Jones Sustainability Index (DJSI), the first time the company has been listed. This move recognizes CCE’s long-term investment in and commitment to sustainability.
The DJSI, reviewed annually by the S&P Dow Jones Index Committee and RobecoSAM, is a global index which tracks the financial performance of leading sustainability-driven companies. It is based on an analysis of financially material economic, environmental and social factors. Companies are only listed in the annual ranking if they are best in class within their industry for sustainability.
In total, 3,000 companies were evaluated for inclusion in the index, with just 3 beverage companies being successful in being named to the DJSI World Index. Coca-Cola Enterprises’ inclusion is due to its success integrating sustainability into its core decision-making, and delivering sound long-term plans for sustainable development.
Coca-Cola Enterprises, Inc. produces, distributes, and markets non-alcoholic beverages in Belgium, continental France, Great Britain, Luxembourg, Monaco, the Netherlands, Norway, and Sweden. The company offers nonalcoholic ready-to-drink beverages with carbonation, counting energy drinks, waters, and flavored waters; and nonalcoholic beverages without carbonation, such as waters and flavored waters, juice and juice drinks, teas, coffees, and sports drinks.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), declined -0.99% to $67.04, during its current trading session.
C.H. Robinson Worldwide, Inc (CHRW) will hold its quarterly conference call to talk about third quarter 2015 results on Wednesday, October 28, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). The results will be released via press release after market close on Tuesday, October 27, 2015. We invite call participants to submit questions in advance of the conference call and we will respond to as many of the questions as we can in the time allowed. To submit your question(s) in advance of the call, please email [email protected].
Hosting the conference call will be John P. Wiehoff, chairman and chief executive officer of C.H. Robinson, and Andrew C. Clarke, chief financial officer of C.H. Robinson.
C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. It offers transportation and logistics services, such as truckload comprising time-definite and expedited truck transportation services; less than truckload services; intermodal transportation, which is shipment service of freight in trailers or containers by combination of truck and rail; and non-vessel ocean common carrier or freight forwarding services, in addition to organizes air shipments and provides door-to-door services.
Aecom (NYSE:ACM), during its Friday’s current trading session decreased -2.09% to $26.74.
AECOM (ACM), a premier, fully integrated global infrastructure firm, declared recently that it has been selected for the project with Arizona Public Service (APS) to engineer, procure and construct (EPC) selective catalytic reduction (SCR) retrofits and related balance of plant equipment at the Four Corners Station near Farmington, N.M.
AECOM will install SCR technology for APS Four Corners units 4 and 5 at the coal-fired power plants. AECOM has a three-decade history that represents the cleaning of more than 25,000 megawatts of coal-plant emissions and is an established market leader in SCR systems design and installation for both grassroots and retrofit projects.
AECOM, together with its auxiliaries, provides professional technical and administration support services for public and private clients worldwide. The company operates through two segments, Professional Technical Services (PTS) and Administration Support Services (MSS).
Finally, Wright Medical Group Inc (NASDAQ:WMGI), gained 2.95%, to $21.28.
Wright Medical Group, Inc. (WMGI) recently declared that its BioMimetic partner has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT® Bone Graft. The approval order indicates that FDA determined that AUGMENT® Bone Graft is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. Wright can now initiate commercial sale and distribution of AUGMENT® Bone Graft in the U.S.
Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients lifestyles worldwide. The company offers products that are used primarily in foot and ankle repair, upper extremity products, and biologics products. Its extremity hardware products comprise implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow, and shoulder.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
